<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM1338415"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">6</item><item key="AGE">60-69</item><item key="HISTOLOGICAL SUBTYPE">serous</item><item key="FIGO STAGE">3c</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">12</item></item></item><item><item key="GSM1338414"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">1</item><item key="AGE">60-69</item><item key="HISTOLOGICAL SUBTYPE">serous</item><item key="FIGO STAGE">3c</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">0</item></item></item><item><item key="GSM1338413"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">4</item><item key="AGE">30-39</item><item key="HISTOLOGICAL SUBTYPE">endometrioid</item><item key="FIGO STAGE">4</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">66</item></item></item><item><item key="GSM1338412"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">0</item><item key="AGE">60-69</item><item key="HISTOLOGICAL SUBTYPE">mucinous</item><item key="FIGO STAGE">1c</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">7</item></item></item><item><item key="GSM13384"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">48</item><item key="AGE">60-69</item><item key="HISTOLOGICAL SUBTYPE">serous</item><item key="FIGO STAGE">3c</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">547</item></item></item><item><item key="GSM1338410"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">6</item><item key="AGE">50-59</item><item key="HISTOLOGICAL SUBTYPE">serous</item><item key="FIGO STAGE">2a</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">163</item></item></item><item><item key="GSM1338409"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">13</item><item key="AGE">30-39</item><item key="HISTOLOGICAL SUBTYPE">clear</item><item key="FIGO STAGE">1a</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">133</item></item></item><item><item key="GSM1338408"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">56</item><item key="AGE">60-69</item><item key="HISTOLOGICAL SUBTYPE">serous</item><item key="FIGO STAGE">3c</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">31</item></item></item><item><item key="GSM1338407"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">0</item><item key="AGE">50-59</item><item key="HISTOLOGICAL SUBTYPE">clear</item><item key="FIGO STAGE">1c</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">0</item></item></item><item><item key="GSM1338406"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">23</item><item key="AGE">50-59</item><item key="HISTOLOGICAL SUBTYPE">serous</item><item key="FIGO STAGE">3b</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">109</item></item></item><item><item key="GSM1338405"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">41</item><item key="AGE">70-79</item><item key="HISTOLOGICAL SUBTYPE">serous</item><item key="FIGO STAGE">2c</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">73</item></item></item><item><item key="GSM1338404"><item key="MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER">1</item><item key="AGE">70-79</item><item key="HISTOLOGICAL SUBTYPE">serous</item><item key="FIGO STAGE">3c</item><item key="MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER">25</item></item></item></item><item key="id">2106</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">PD-L1 suppresses host immunity and promotes tumor growth. We investigated how IFN-&#947; regulates PD-L1 in the ovarian cancer...</item><item key="geo_gse_id">E-GEOD-55512</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">5</item><item key="sample_count">12</item><item key="tags"><item>cancer</item><item>cell</item><item>epithelial cell</item><item>genome</item><item>line</item><item>lymphocyte</item><item>ovarian cancer</item><item>surface</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">gene-expression-profiles-of-ovarian-cancer-regardi</item><item key="geo_id_plat">E-GEOD-55512_A-AFFY-44</item><item key="name">Gene-expression profiles of ovarian cancer regarding its microenvironment</item><item key="created">Jul.11, 2014</item><item key="summary">PD-L1 suppresses host immunity and promotes tumor growth. We investigated how IFN-&#947; regulates PD-L1 in the ovarian cancer microenvironment.  In clinical samples, the number of stromal CTLs in peritoneally disseminated tumors was correlated with PD-L1 expression on the tumor cells, and the lymphocyte number was significantly related to the IFN-&#947; signature score. In mouse models, PD-L1 was induced in peritoneal disseminated tumors, where lymphocytes were prominent, but not in subcutaneous tumors. Depleting IFNGR1 resulted in lower PD-L1 expression and longer survival in peritoneal dissemination model. Injection of IFN-&#947; into subcutaneous tumors increased PD-L1 expression and tumor size, and PD-L1 depletion abrogated tumor growth. These data suggest that IFN-&#947; works as a tumor progressor through PD-L1 induction. The source of IFN-&#947; in ovarian cancer microenvironment and its biological effect to the tumor cells is unclear. The immortalized human ovarian surface epithelial cell line, HOSE-E7/hTERT (HOSE) was treated with IFN-&#947; and expression microarray analysis was performed, and probes showing significantly higher values in IFN-&#947;-added group were termed &#8220;IFN-&#947; signature genes (295 probes)&#8221;.  We then applied this signature to our ovarian cancer microarray data, which included 75 ovarian cancer clinical samples, by means of ss-GSEA. IFN-&#947; signature score was strongly correlated to the number of infiltrating CD4-positive or CD8-positive lymphocytes in the tumors. These data suggest that the IFN-&#947; in the ovarian cancer microenvironment is derived from lymphocytes, and an IFN-&#947;-rich microenvironment is strongly correlated to a lymphocyte-rich microenvironment. Genome-wide transcriptional changes in human ovarian cancer tissue were observed in different tumor immunological microenvironment.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-55512</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-55512/samples/</item></data></biogps>
